D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AMAM holding history
Ambrx Biopharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMAM overviewAll 13F holders of AMAMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −4,240,486−100.0% | Sold out | Holders |
| Q4 2023 | 4,240,486 | $60.4M | 0.1% | +235,973+5.9% | Added | Holders |
| Q3 2023 | 4,004,513 | $46.1M | 0.1% | −11,395−0.3% | Reduced | Holders |
| Q2 2023 | 4,015,908 | $66.1M | 0.1% | +82,356+2.1% | Added | Holders |
| Q1 2023 | 3,933,552 | $35.1M | 0.1% | +3,933,552 | New | Holders |